Light-emitting device and medical device using the same

By using high-energy density solid light emitting elements and wavelength converters in photodynamic therapy, efficient excitation and deep irradiation of photosensitive substances are achieved, the problem of insufficient near-infrared light energy in the prior art is solved, and treatment is improved Effect.

CN113396487BActive Publication Date: 2024-12-03PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202080012464.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-01-27
Publication Date
2024-12-03
Estimated Expiration
2040-01-27

AI Technical Summary

Technical Problem

The near-infrared light emitted by the existing photodynamic therapy light emitting device is low, which makes the photosensitive substances unable to fully stimulate and makes it difficult to effectively illuminate the deep part of the biological body.

Method used

The solid light emitting element and a wavelength converter are used. The solid light emitting element emits primary light with an energy density of 0.5W/mm2 or more. The wavelength converter includes a phosphor that emits a range of 700nm to 800nm. The phosphor energy is 100mW or more, and passes efficient light It can convert near-infrared light that achieves high output.

Benefits of technology

It achieves efficient excitation of photosensitive substances, can deeply irradiate photosensitive substances in biological bodies, and improves the therapeutic effect of photodynamic therapy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113396487B_ABST
    Figure CN113396487B_ABST
Patent Text Reader

Abstract

The light emitting device (1) of the present invention is a light emitting device for photodynamic therapy. The light emitting device comprises a solid light emitting element (2) and a wavelength converter (3). The solid light emitting element (2) emits an energy density of 0.5 W / mm 2 The wavelength converter (3) includes a first phosphor (4) that emits a first wavelength converted light (7). The first wavelength converted light has a light component in the entire wavelength range of at least 700 nm and less than 800 nm. The energy of the fluorescence emitted by the wavelength converter is 100 mW or more. A medical device is provided with the light emitting device.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a light emitting device and a medical device using the light emitting device. Background Art

[0002] In recent years, a treatment method for tumors called photodynamic therapy (PDT) has attracted attention. Photodynamic therapy is a treatment method that applies a photosensitive substance that selectively binds to the tumor to the subject and then irradiates the photosensitive substance with light. By irradiating the photosensitive substance bound to the tumor with light, the photosensitive substance emits heat and active oxygen species, thereby destroying the tumor through heat and active oxygen species. This type of photodynamic therapy is less likely to cause damage to normal biological tissues, so it can be said to be a treatment method that places less burden on patients.

[0003] In the case of photodynamic therapy, near-infrared light is used as light for irradiating photosensitivity substances. Near-infrared light is less affected by absorption and scattering by hemoglobin and water in the body, and is therefore easily transmitted through the body. Therefore, by using near-infrared light, tumors located inside the body can be treated. In addition, light in a wavelength range of 650 nm or more and less than 1400 nm is particularly easy to be transmitted through the body, and this wavelength range is generally referred to as a biological window.

[0004] As a light emitting device emitting near-infrared light, Patent Document 1 discloses a beam emitting optoelectronic element using a specific wavelength conversion material. Patent Document 1 further describes that the optoelectronic element is used in an endoscope, and the endoscope is suitable for photodynamic diagnosis and photodynamic therapy.

[0005] Prior art literature

[0006] Patent Literature

[0007] Patent Document 1: Japanese Patent Application No. 2018-518046 Summary of the invention

[0008] However, in Patent Document 1, the energy of the near-infrared light emitted by the light-emitting device using the optoelectronic element is as low as less than 50 mW. Therefore, there is a problem that even if the photosensitive substance is irradiated with the near-infrared light emitted by the light-emitting device, the photosensitive substance cannot fully function. In addition, when the energy of the near-infrared light is low, there is a problem that the photosensitive substance located deep in the biological body cannot be fully irradiated with the near-infrared light.

[0009] The present invention has been made in view of the problems of the prior art. Another object of the present invention is to provide a light emitting device capable of emitting near-infrared light that can efficiently excite a photosensitive substance, and a medical device using the light emitting device.

[0010] In order to solve the above problems, a first embodiment of the present invention is a light emitting device for photodynamic therapy. The light emitting device comprises a solid light emitting element and a wavelength converter, wherein the solid light emitting element emits an energy density of 0.5 W / mm 2 The wavelength converter includes a first phosphor that emits a first wavelength converted light. The first wavelength converted light has a light component in the entire wavelength range of at least 700 nm and less than 800 nm. The energy of the fluorescence emitted by the wavelength converter is 100 mW or more.

[0011] A medical device according to a second aspect of the present invention includes the light emitting device according to the first aspect. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] Figure 1 It is a schematic cross-sectional view showing an example of the light emitting device according to this embodiment.

[0013] Figure 2 It is a schematic cross-sectional view showing another example of the light emitting device according to the present embodiment.

[0014] Figure 3 It is a schematic cross-sectional view showing another example of the light emitting device according to the present embodiment.

[0015] Figure 4 It is a schematic cross-sectional view showing another example of the light emitting device according to the present embodiment.

[0016] Figure 5 This is a graph that abstractly shows the relationship between the light emission spectrum of the light emitting device of this embodiment and the absorption spectrum of the photosensitizing substance.

[0017] Figure 6 It is a diagram schematically showing the structure of the endoscope according to the present embodiment.

[0018] Figure 7 It is a diagram schematically showing the configuration of an endoscope system according to the present embodiment.

[0019] Figure 8 It is a graph showing the X-ray diffraction pattern of the phosphor used in the light-emitting device of Example 4 and the pattern of CaSc2O4 registered in ICSD.

[0020] Fig. 9 This is a graph showing the excitation spectrum and emission spectrum of the phosphor used in the light-emitting device of Example 1.

[0021] Fig.10 This is a graph showing the excitation spectrum and emission spectrum of the phosphor used in the light-emitting device of Example 2.

[0022] Fig.11 This is a graph showing the emission spectrum of the phosphor used in the light-emitting device of Example 3.

[0023] Fig.12 This is a graph showing the emission spectrum of the phosphor used in the light-emitting device of Example 4.

[0024] Fig.13 This is a graph showing the emission spectrum of the phosphor used in the light-emitting device of Example 5.

[0025] Fig.14 This is a graph showing the excitation spectrum and emission spectrum of the phosphor used in the light-emitting device of Example 6.

[0026] Fig.15 This is a graph showing the emission spectrum of the phosphor used in the light-emitting device of Example 7. DETAILED DESCRIPTION

[0027] Hereinafter, the light emitting device of the present embodiment and the medical device and photodynamic therapy using the light emitting device will be described with reference to the drawings. In addition, for the sake of convenience of description, the dimensional ratios of the drawings are exaggerated and may be different from the actual ratios.

[0028] [Light-emitting device]

[0029] The light-emitting device of this embodiment is a light-emitting device for photodynamic therapy. Figure 1 to Figure 4 As shown, the light emitting device 1, 1A, 1B, 1C comprises at least a solid light emitting element 2 and a wavelength converter 3, 3A including a first phosphor 4 that emits a first wavelength converted light 7. In the light emitting device 1, 1A, 1B, 1C, when the primary light 6 emitted from the solid light emitting element 2 enters the wavelength converter 3, 3A, the wavelength converter 3, 3A emits fluorescence.

[0030] (Solid-state light-emitting device)

[0031] The solid-state light emitting element 2 is a light emitting element that emits primary light 6. As such a solid-state light emitting element 2, for example, a laser element such as a surface-emitting laser diode is used. The output energy of the laser light emitted by one laser element is, for example, 0.1 W or more, more preferably 1 W or more, and further preferably 5 W or more. In addition, the energy density of the laser light emitted by the solid-state light emitting element 2 is, for example, 0.5 W / mm 2 More preferably 2W / mm 2 More preferably, 10W / mm 2As described later, the phosphor in the wavelength converter 3, 3A can convert the wavelength of high-output laser light with high efficiency, and is not easily degraded even for high-output laser light. Therefore, by making the energy density of the laser light emitted by the solid-state light emitting element 2 0.5 W / mm 2 As described above, the light emitting device can radiate high-output near-infrared light.

[0032] The solid-state light-emitting element 2 included in the light-emitting device 1, 1A, 1B, 1C may be a light-emitting diode (LED). For example, by using an LED that emits light with an energy of 100 mW or more as the solid-state light-emitting element 2, the phosphor in the wavelength converter 3, 3A can be excited with high-output light. As a result, the light-emitting device 1, 1A, 1B, 1C can emit high-output near-infrared light and can exert the same effect as when a laser element is used.

[0033] As described above, in the light emitting devices 1, 1A, 1B, and 1C, the solid light emitting element 2 is preferably at least one of a laser element and a light emitting diode. However, the solid light emitting element 2 is not limited to these, and any light emitting element can be used as long as it can emit primary light 6 with a high energy density. Specifically, the solid light emitting element 2 preferably emits primary light 6 with an energy density of 0.5 W / mm 2 In this case, the phosphor in the wavelength converter 3 and 3A is excited by the high-output light, so the light-emitting device 1, 1A, 1B, 1C can radiate high-output near-infrared light. In addition, the energy density of the primary light emitted by the solid-state light-emitting element 2 is more preferably 2 W / mm 2 More preferably, 10W / mm 2 The upper limit of the energy density of the primary light emitted by the solid-state light emitting element 2 is not particularly limited, and can be set to 50 W / mm 2 .

[0034] The solid-state light emitting element 2 preferably emits primary light 6 having an intensity maximum in the wavelength range of 430 nm to 480 nm. In addition, the solid-state light emitting element 2 preferably includes a blue laser element as an excitation source and emits blue primary light 6. As a result, the phosphor in the wavelength converter 3, 3A is excited with high efficiency, so that the light emitting device can emit high-output near-infrared light.

[0035] The solid-state light emitting element 2 can emit primary light 6 having a maximum intensity in the wavelength range of 500 nm to 560 nm. Thus, the high-output primary light 6 can excite the phosphor in the wavelength converter 3 or 3A, and the light emitting device can emit high-output near-infrared light.

[0036] The solid-state light emitting element 2 can emit primary light 6 having a maximum intensity in the wavelength range of 600 nm to 700 nm. Thus, the phosphor in the wavelength converter 3, 3A is excited by relatively low-energy red light, thereby obtaining a light emitting device that emits high-output near-infrared light with little heat generation due to Stokes loss of the phosphor.

[0037] As described above, the types of solid-state light-emitting elements 2 provided in the light-emitting devices 1, 1A, 1B, and 1C are not particularly limited. However, the types of solid-state light-emitting elements 2 provided in the light-emitting devices 1, 1A, 1B, and 1C are preferably three or less, more preferably two or less, and even more preferably one. By setting such a configuration, a simple configuration with a small number of types of solid-state light-emitting elements 2 is obtained, so that a compact light-emitting device 1, 1A, 1B, and 1C can be obtained.

[0038] The light emitting devices 1, 1A, 1B, 1C may further include a laser element that does not excite the wavelength converter 3, 3A. Thus, a light emitting device for a medical device that can use both photodynamic therapy using near-infrared light emitted by the wavelength converter 3, 3A and other treatments using laser light emitted by the laser element that does not excite the wavelength converter 3, 3A can be obtained. In addition, other treatments using laser light emitted by the laser element include: treatment using optical coherence tomography, treatment using fluorescence imaging such as ICG fluorescence imaging, treatment using narrow band imaging (Narrow Band Imaging (NBI)), laser scalpel treatment, and the like.

[0039] The solid-state light emitting elements included in the light emitting devices 1, 1A, 1B, 1C preferably include a plurality of the same elements. With such a configuration, the wavelength converters 3, 3A can be excited with light of higher energy, thereby obtaining a light emitting device that emits near-infrared light with higher output.

[0040] (Wavelength Converter)

[0041] like Figure 1 to Figure 4 As shown, the wavelength converters 3 and 3A emit fluorescence having a longer wavelength than the primary light 6 by receiving the primary light 6 . Figure 1 and Figure 2 The wavelength converter 3, 3A shown in the figure is configured to receive the primary light 6 at the front surface 3a and emit fluorescence at the back surface 3b. Figure 3 and Figure 4 The wavelength converter 3 , 3A shown in the figure has a structure that receives the primary light 6 at the front surface 3 a and emits fluorescence at the same front surface 3 a .

[0042] The wavelength converter 3, 3A includes a first phosphor 4 that receives the primary light 6 and emits the first wavelength converted light 7, and the first wavelength converted light 7 has a light component in the entire wavelength range of at least 700nm to 800nm. Therefore, the light emitting device 1, 1A, 1B, 1C can emit a continuous spectrum of light having a light component in the wavelength range of at least 700nm to 800nm.

[0043] The first phosphor 4 included in the wavelength converter 3 or 3A is not particularly limited as long as the first wavelength converted light 7 has a light component in the entire wavelength range of at least 700 nm to 800 nm. However, the first phosphor 4 preferably includes Eu 2+ Activate phosphor and Ce 3+ Activate at least one of the phosphors. 3+ and Eu 2+ Take based on The mechanism of light absorption and luminescence that allows transitions. Therefore, the wavelengths of absorption and luminescence vary depending on the parent crystal that makes them activated. 3+ or Eu 2+ By selecting an appropriate mother crystal for the luminescent center, a fluorescent component with a smooth band spectrum can be obtained at least in the wavelength range of 700nm to 800nm. Allowing transition, Ce 3+ Equivalent to n = 1, Eu 2+ Equivalent to n=7.

[0044] The first phosphor 4 preferably contains at least Cr 3+ Activate phosphor. Cr 3+ The mechanism of light absorption and luminescence based on dd transition is adopted. Therefore, the wavelength of absorption and luminescence depends on the Cr 3+ Therefore, by using Cr 3+ By selecting an appropriate mother crystal for the luminescent center, it is possible to obtain a fluorescent component that forms a smooth band spectrum in at least the wavelength range of 700nm to 800nm.

[0045] The first phosphor 4 is preferably an oxide phosphor, more preferably an oxide phosphor. The oxide phosphor refers to a phosphor containing oxygen but not nitrogen, and examples thereof include alkaline earth metal oxides, alkaline earth metal halogenated aluminates, and rare earth aluminates having a calcium ferrite structure.

[0046] Oxides are stable substances in the atmosphere, so even when an oxide phosphor generates heat due to high-density light excitation based on laser light, it is not easy for the phosphor crystal to deteriorate due to oxidation in the atmosphere as occurs in nitride phosphors. Therefore, when all phosphors included in the wavelength converter 3, 3A are oxide phosphors, a light-emitting device with high reliability can be obtained.

[0047] The first phosphor 4 is preferably a nitride-based phosphor, and more preferably a nitride-based phosphor. In addition, the first phosphor 4 is preferably a nitride-based phosphor, and more preferably a nitride-based phosphor. Nitrides have strong covalent bonding properties, and various modifications can be adopted in terms of composition, so it is easy to control the fluorescent color and improve temperature quenching. In addition, the thermal conductivity is also excellent, which is conducive to the miniaturization of the light-emitting device. Therefore, when all the phosphors included in the wavelength converter 3, 3A are nitride-based phosphors, it becomes easy to control the color tone of the light emitted by the light-emitting device, and it also becomes easy to design a smaller device.

[0048] The first phosphor 4 preferably has a garnet crystal structure. In addition, the first phosphor 4 is also preferably an oxide phosphor having a garnet crystal structure. The phosphor having a garnet structure, especially the oxide, has a polyhedral particle shape close to a sphere, and the dispersibility of the phosphor particle group is excellent. Therefore, in the case where the phosphor included in the wavelength converter 3, 3A has a garnet structure, it is relatively easy to manufacture a wavelength converter with excellent light transmittance, and it is possible to achieve high output of the light-emitting device. In addition, the phosphor having a garnet crystal structure has practical results as a phosphor for LED, so by making the first phosphor 4 have a garnet crystal structure, a light-emitting device with high reliability can be obtained.

[0049] The first phosphor 4 is preferably a phosphor formed by using as a matrix a compound having as a main component at least one selected from rare earth silicates, rare earth aluminates, rare earth gallates, rare earth scandates, rare earth aluminum silicates, alkaline earth metal nitride aluminum silicates, and rare earth nitride silicates. Alternatively, the first phosphor 4 is preferably a phosphor formed by using as a matrix at least one selected from rare earth silicates, rare earth aluminates, rare earth aluminum silicates, alkaline earth metal nitride aluminum silicates, and rare earth nitride silicates. By using such a first phosphor 4, a part of the primary light 6 can be easily converted into near-infrared light. Therefore, near-infrared light having a large half-peak width of the fluorescence spectrum can be obtained.

[0050] Specifically, the first phosphor 4 is preferably selected from RE2MMg(SiO4)3, RE3Al2(AlO4)3, RE3Ga2(GaO4)3, RE3Sc2(GaO4)3, RE3Sc2(ScO4)3, RE3Mg2(SiO4)2(AlO4), MRE2O4, MAlSiN3 and RE3Si6N 11 Alternatively, the first phosphor 4 is preferably a phosphor selected from RE2MMg(SiO4)3, RE3Al2(AlO4)3, RE3Mg2(SiO4)2(AlO4), MRE2O4, MAlSiN3 and RE3Si6N 11 Alternatively, the first phosphor 4 is preferably a phosphor formed by using a solid solution having the compound (A) as a terminal component as a matrix. In addition, M is an alkaline earth metal, and RE is a rare earth element.

[0051] The first phosphor 4 is preferably formed of ceramics. This improves the heat dissipation of the first phosphor 4, thereby suppressing a decrease in the output of the first phosphor 4 due to temperature quenching, and obtaining a light-emitting device that emits high-output near-infrared light.

[0052] As described above, in the light-emitting devices 1, 1A, 1B, and 1C, the first wavelength-converted light 7 emitted by the first phosphor 4 has a light component at least in the entire wavelength range of 700 nm to 800 nm. Thus, the photosensitizing substance can function efficiently. However, it is more preferable that the first wavelength-converted light 7 has a light component at least in the entire wavelength range of 750 nm to 800 nm. In addition, it is preferable that the first wavelength-converted light 7 has a light component at least in the entire wavelength range of 600 nm to 800 nm. Furthermore, the fluorescence peak of the first wavelength-converted light 7 emitted by the first phosphor 4 is preferably in the wavelength range of 600 nm to 1000 nm, and more preferably in the wavelength range of 700 nm to 1000 nm. Thus, the photosensitizing substance can absorb the light component in the near-infrared region emitted by the first phosphor 4 more efficiently. In addition, it is a configuration that can correspond to various types of photosensitizing substances with different light absorption characteristics. Therefore, a light-emitting device that can increase the amount of heat and active oxygen species emitted by the photosensitizing substance and can correspond to various photodynamic therapies can be provided.

[0053] The 1 / e fluorescence lifetime of the first wavelength converted light 7 emitted by the first phosphor 4 is preferably 20 ns to 1000 μs, and more preferably 20 ns or more and less than 100 μs. In addition, the 1 / e fluorescence lifetime of the first wavelength converted light 7 is further preferably 20 ns or more and less than 2000 ns, and particularly preferably 20 ns or more and less than 100 ns. Thus, even when the optical density of the excitation light that excites the first phosphor 4 is high, the output of the fluorescence emitted by the first phosphor 4 is not easily saturated. Therefore, a light-emitting device capable of emitting high-output near-infrared light can be obtained.

[0054] like Figure 1 As shown, the wavelength converter 3 preferably has a sealing material 5 in which the first phosphor 4 is dispersed in addition to the first phosphor 4. Moreover, in the wavelength converter 3, it is preferred that the first phosphor 4 is dispersed in the sealing material 5. By dispersing the first phosphor 4 in the sealing material 5, the primary light 6 emitted by the solid-state light emitting element 2 can be efficiently absorbed and the wavelength can be converted into near-infrared light. In addition, the wavelength converter 3 can be easily formed into a sheet or film.

[0055] The sealing material 5 is preferably at least one of an organic material and an inorganic material, and is particularly preferably at least one of a transparent (light-transmitting) organic material and a transparent (light-transmitting) inorganic material. As the sealing material of the organic material, for example, a transparent organic material such as silicone resin can be listed. As the sealing material of the inorganic material, for example, a transparent inorganic material such as low-melting-point glass can be listed.

[0056] like Figure 1 and Figure 3 As shown in FIG. 1 , the wavelength converter 3 includes a first phosphor 4 that emits a first wavelength converted light 7. Figure 2 and Figure 4 As shown, the wavelength converter preferably further includes a second phosphor 8, which absorbs the primary light 6 emitted by the solid-state light emitting element 2 and emits a second wavelength converted light 9 as visible light. By making the wavelength converter 3A include the second phosphor 8, white output light can be emitted by additive color mixing with the primary light 6 emitted by the solid-state light emitting element 2, such as blue laser light.

[0057] The second phosphor 8 included in the wavelength converter 3A is not particularly limited as long as it can absorb the primary light 6 emitted by the solid-state light emitting element 2 and emit the second wavelength converted light 9 as visible light. The second phosphor 8 is preferably a crystalline structure selected from a garnet type, a calcium ferrite type, and a lanthanum silicon nitride (La3Si6N 11 )-type crystal structure of the compound group having at least one of the main components of the compound as a matrix Ce 3+Alternatively, the second phosphor 8 is preferably Ce, which is formed by using as a matrix at least one compound selected from the group consisting of compounds having a garnet-type crystal structure, a calcium ferrite-type crystal structure, and a lanthanum silicon nitrogen-type crystal structure. 3+ Activating the phosphor. By using such a second phosphor 8, it is possible to obtain output light having a large amount of green to yellow light components.

[0058] Specifically, the second phosphor 8 is preferably selected from M3RE2(SiO4)3, RE3Al2(AlO4)3, MRE2O4 and RE3Si6N 11 Ce having at least one compound (B) as a main component as a matrix 3+ Alternatively, the second phosphor 8 is preferably selected from M3RE2(SiO4)3, RE3Al2(AlO4)3, MRE2O4 and RE3Si6N 11 Ce as a matrix of at least one 3+ Alternatively, the second phosphor 8 is preferably Ce, which is a solid solution having the compound (B) as a terminal component as a matrix. 3+ Activate the phosphor. In addition, M is an alkaline earth metal and RE is a rare earth element.

[0059] Such a second phosphor 8 fully absorbs light in the wavelength range of 430nm to 480nm and efficiently converts it into green to yellow light having an intensity maximum in the wavelength range of 540nm to 590nm. Therefore, by using such a phosphor as the second phosphor 8, it is possible to easily obtain a visible light component.

[0060] When the wavelength converter 3A includes the first phosphor 4 and the second phosphor 8, the first phosphor 4 preferably emits the first wavelength converted light 7 by absorbing at least one of the primary light 6 emitted by the solid-state light emitting element 2 and the second wavelength converted light 9 emitted by the second phosphor 8. As described above, the first phosphor 4 is preferably a phosphor that absorbs the primary light 6 emitted by the solid-state light emitting element 2 and emits the first wavelength converted light 7 as near-infrared light. However, the first phosphor 4 may be a phosphor that absorbs the second wavelength converted light 9 emitted by the second phosphor 8 and emits the first wavelength converted light 7 as near-infrared light. That is, the second phosphor 8 can be excited by the primary light 6 to emit the second wavelength converted light 9, and the first phosphor 4 can be excited by the second wavelength converted light 9 to emit the first wavelength converted light 7. In this case, even if the first phosphor 4 is a phosphor that is hardly excited by the primary light 6, it can be excited by the fluorescence emitted by the second phosphor 8 through the second phosphor 8. As a result, as the first phosphor 4, a phosphor that absorbs visible light can be selected, so the selection of the first phosphor 4 is widened, and it becomes a light-emitting device that is easy to industrially produce. Furthermore, when the first phosphor 4 absorbs the second wavelength converted light 9 and emits the first wavelength converted light 7 , the light emitting device can emit the first wavelength converted light 7 having a high intensity of near-infrared light components.

[0061] The wavelength converter 3, 3A is preferably formed of an inorganic material. Here, the inorganic material refers to a material other than an organic material, and is a concept including ceramics and metals. By forming the wavelength converter 3, 3A from an inorganic material, the thermal conductivity thereof is higher than that of a wavelength converter including an organic material such as a sealing resin, so that the heat dissipation design becomes easy. Therefore, even when the primary light 6 emitted by the solid light emitting element 2 is photoexcited at a high density to the phosphor, the temperature rise of the wavelength converter 3, 3A can be effectively suppressed. As a result, the temperature quenching of the phosphor in the wavelength converter 3, 3A can be suppressed to achieve high output of light emission.

[0062] As described above, the wavelength converters 3 and 3A are preferably formed of an inorganic material, and therefore the sealing material 5 is preferably formed of an inorganic material. In addition, zinc oxide (ZnO) is preferably used as the inorganic material. As a result, the heat release of the phosphor is further improved, so that the output reduction of the phosphor caused by temperature quenching can be suppressed, and a light-emitting device emitting high-output near-infrared light can be obtained.

[0063] In addition, the wavelength converter 3, 3A can also be set as a wavelength converter without using the sealing material 5. In this case, the phosphors can be fixed to each other using an organic or inorganic binder. In addition, the phosphors can be fixed to each other using a heating reaction of the phosphor. As the binder, a commonly used resin-based adhesive or ceramic particles, low-melting-point glass, etc. can be used. The wavelength converter without using the sealing material 5 can be thinned, so it can be applied to a light-emitting device.

[0064] Next, the function of the light emitting device of this embodiment will be described. Figure 1 For the light emitting device 1 shown, first, the primary light 6 emitted by the solid light emitting element 2 is irradiated to the front surface 3a of the wavelength converter 3. The irradiated primary light 6 is transmitted from the wavelength converter 3. Moreover, when the primary light 6 is transmitted from the wavelength converter 3, the first phosphor 4 included in the wavelength converter 3 absorbs a part of the primary light 6 and emits the first wavelength converted light 7. In this way, the light including the primary light 6 and the first wavelength converted light 7 is emitted from the back surface 3b of the wavelength converter 3 as output light.

[0065] At once Figure 2 For the light-emitting device 1A shown, first, the primary light 6 emitted by the solid-state light-emitting element 2 is irradiated toward the front surface 3a of the wavelength converter 3A. The irradiated primary light 6 is transmitted through the wavelength converter 3A. Moreover, when the primary light 6 is transmitted through the wavelength converter 3A, the second phosphor 8 included in the wavelength converter 3A absorbs a part of the primary light 6 and emits the second wavelength converted light 9. Furthermore, the first phosphor 4 included in the wavelength converter 3A absorbs a part of the primary light 6 and / or the second wavelength converted light 9 and emits the first wavelength converted light 7. In this way, light including the primary light 6, the first wavelength converted light 7, and the second wavelength converted light 9 is emitted as output light from the back surface 3b of the wavelength converter 3A.

[0066] At once Figure 3 In the light emitting device 1B shown, first, the primary light 6 emitted by the solid light emitting element 2 irradiates the front surface 3a of the wavelength converter 3. A large amount of the primary light 6 enters the wavelength converter 3 from the front surface 3a of the wavelength converter 3, and the other part is reflected from the front surface 3a. In the wavelength converter 3, the first phosphor 4 excited by the primary light 6 emits the first wavelength converted light 7, and the first wavelength converted light 7 is emitted from the front surface 3a.

[0067] At once Figure 4In the light-emitting device 1C shown, first, the primary light 6 emitted by the solid-state light-emitting element 2 is irradiated onto the front surface 3a of the wavelength converter 3A. A large amount of the primary light 6 is incident into the wavelength converter 3A from the front surface 3a of the wavelength converter 3A, and the other part is reflected from the front surface 3a. In the wavelength converter 3A, the second phosphor 8 excited by the primary light 6 emits the second wavelength converted light 9, and the first phosphor 4 excited by the primary light 6 and / or the second wavelength converted light 9 emits the first wavelength converted light 7. Then, the first wavelength converted light 7 and the second wavelength converted light 9 are emitted from the front surface 3a.

[0068] As described above, the light emitting device of this embodiment emits the first wavelength converted light 7 having light components throughout at least the wavelength range of 700 nm to 800 nm, so that the photosensitizing substance applied to the subject can function efficiently by the first wavelength converted light 7 .

[0069] Here, the photosensitizing substance used for photodynamic therapy is not particularly limited as long as it absorbs the first wavelength converted light 7 to emit at least one of heat and active oxygen species and has the ability to destroy tumors. For example, the photosensitizing substance can be at least one selected from phthalocyanine compounds, porphyrin compounds, chlorin compounds, bacteriochlorin compounds, psoralen compounds, porfimer sodium compounds, and talaporfin sodium compounds. In addition, photosensitizing substances are sometimes also referred to as photosensitizing agents, photosensitizing compounds, photosensitizers, exothermic substances, etc.

[0070] For such photosensitizing substances, the light absorption characteristics may sometimes change in the subject due to the solvatochromic effect (the effect of the ground state and the excited state changing due to the change in the polarity of the solvent) and the change in electron-withdrawing property caused by association (the binding of the same molecules to each other due to intermolecular forces). In addition, for photosensitizing substances, the light absorption characteristics may sometimes change in the subject depending on the types of functional groups, substituents, and side chains introduced to make them accumulate in parts (affected parts) such as tumors. Therefore, in the case where the spectral width of the light irradiated to the photosensitizing substance is narrow or the spectrum of the light irradiated to the photosensitizing substance is constant, it is impossible to correspond to the changes in the light absorption characteristics of the photosensitizing substance. As a result, the conversion efficiency of the photosensitizing substance from light energy to heat energy and the generation efficiency of active oxygen are sometimes reduced.

[0071] In contrast, in the light-emitting device of this embodiment, even when the light absorption characteristics of the photosensitizing substance change, the photosensitizing substance can be excited efficiently. Figure 5 The image shows the relationship between the emission spectrum of the light-emitting device of this embodiment and the absorption spectrum of the photosensitive substance. As described above, the light absorption characteristics of the photosensitive substance may change depending on the solvent-induced color effect, the type of functional group, substituent, side chain, etc. Figure 5As shown in FIG. 1 , the peak wavelength of the absorption spectrum of the photosensitivity substance changes slightly due to these effects. However, the light emitting device of the present embodiment continuously emits light components as a whole at least in the wavelength range of 700 nm to 800 nm. Therefore, even when the light absorption characteristics of the photosensitivity substance change, the absorption spectrum of the photosensitivity substance and the emission spectrum of the first wavelength converted light 7 have a large overlap. As a result, the photosensitivity substance efficiently absorbs the first wavelength converted light 7, so the photosensitivity substance can be efficiently excited to generate a large amount of heat and active oxygen species.

[0072] In the light emitting devices 1, 1A, 1B, and 1C of the present embodiment, the energy of the fluorescence (fluorescence beam) emitted by the wavelength converter 3 is 100 mW or more. That is, the energy density of the solid light emitting element 2 irradiating the wavelength converter 3 is 0.5 W / mm 2 The primary light 6 is higher than 100 mW, so the energy of the fluorescence emitted by the wavelength converter 3 becomes 100 mW or more. In this case, the first wavelength converted light 7 emitted by the wavelength converter 3 becomes high intensity, so that the photosensitive substance in the subject can be more efficiently excited and the photosensitive substance can fully function. In addition, when the energy of the fluorescence emitted by the wavelength converter 3 is high, the photosensitive substance located deep in the biological body can be efficiently excited and the photosensitive substance can function. In addition, the energy of the fluorescence emitted by the wavelength converter 3 is preferably 300 mW or more, more preferably 500 mW or more, and further preferably 1 W or more. The upper limit of the energy of the fluorescence emitted by the wavelength converter 3 is not particularly limited, and can be set to 10 W, for example.

[0073] Thus, the light emitting devices 1, 1A, 1B, and 1C of the present embodiment are light emitting devices for photodynamic therapy, and have an emission energy density of 0.5 W / mm 2 The solid light emitting element 2 of the primary light 6 and the wavelength converter 3 including the first phosphor 4 emitting the first wavelength converted light 7. The first wavelength converted light 7 has a light component in the wavelength range of at least 700nm and less than 800nm. In addition, the energy of the fluorescence emitted by the wavelength converter 3 is 100mW or more. The light emitting devices 1, 1A, 1B, 1C emit light having a light component in the wavelength range of at least 700nm to 800nm, so that even if the photosensitive substance undergoes a characteristic change, the photosensitive substance can be efficiently excited. In addition, the energy of the fluorescence emitted by the wavelength converter 3 is 100mW or more, so that the photosensitive substance can be efficiently excited and the photosensitive substance can fully function.

[0074] In addition, the primary light 6 may be included in the output light of the light emitting device 1, 1A, 1B, 1C. In this way, a light emitting device that uses the primary light 6 having a wavelength different from the first wavelength converted light 7 and is suitable for a medical device that can use photodynamic therapy and other treatments together can be obtained. As other treatments, for example, treatment using a narrow-band imaging method can be listed. In addition, the primary light 6 may not be included in the output light of the light emitting device 1, 1A, 1B, 1C. In this way, only the first wavelength converted light 7 becomes the output light, and a light emitting device suitable for photodynamic therapy with less noise components can be obtained.

[0075] The solid-state light emitting element 2 is preferably a blue laser element that emits laser light having a maximum intensity in the wavelength range of 430 nm to 480 nm. The blue laser element has a higher output than a laser element that emits near-infrared light. Therefore, by combining the blue laser element with the wavelength converter 3, 3A, it is possible to emit near-infrared light with a higher output than before, and it is possible to efficiently excite the photosensitive substance in the subject.

[0076] In the light emitting devices 1A and 1C, the wavelength converter preferably includes a second phosphor 8 that emits a second wavelength converted light 9 as visible light, in addition to the first phosphor 4 that emits the first wavelength converted light 7. Thus, the surface of the in vivo tissue can be irradiated with the second wavelength converted light 9 and the surface state of the in vivo tissue can be observed.

[0077] In addition, for the light-emitting devices 1A and 1C, the peak wavelength of the fluorescence emitted by the second phosphor 8 is within the wavelength range of 500nm to 700nm, and the solid-state light-emitting element 2 is more preferably equipped with a blue laser element as an excitation source. Thus, the light-emitting device can emit a white light component through additive mixing of the second wavelength converted light 9 emitted by the second phosphor 8 and the blue light component emitted by the solid-state light-emitting element 2. Therefore, the surface state of the in vivo tissue can be observed by irradiating the white light component to the surface of the in vivo tissue. In addition, a phosphor with high practical performance can be used as the second phosphor 8, and a blue semiconductor laser element that is easy to purchase on the market, relatively cheap and has high practical performance can be used as the solid-state light-emitting element 2. Therefore, a light-emitting device suitable for industrial production can be easily obtained.

[0078] In addition, the light emitting devices 1, 1A, 1B, 1C may further include a lens for focusing the first wavelength converted light 7 and the second wavelength converted light 9. Thus, the wavelength converted light emitted by the wavelength converter 3, 3A can be efficiently irradiated to the affected part, thereby obtaining a light emitting device with higher observation accuracy and treatment ability.

[0079] As described above, the light emitting devices 1, 1A, 1B, and 1C can be used for photodynamic therapy using photosensitizing substances such as phthalocyanine compounds, porphyrin compounds, porphin compounds, bacteriochlorin compounds, psoralen compounds, porfimer sodium compounds, and talaporfin sodium compounds. However, the photodynamic therapy using the light emitting devices 1, 1A, 1B, and 1C is not limited to these, and can also be used for photodynamic therapy using photosensitizing substances having an absorption spectrum in the near-infrared light region (e.g., a wavelength range of 650 nm or more and less than 1400 nm).

[0080] [Medical Devices]

[0081] Next, a medical device according to the present embodiment will be described. Specifically, as an example of the medical device, an endoscope including a light emitting device and an endoscope system using the endoscope will be described.

[0082] The endoscope of this embodiment includes the above-mentioned light emitting devices 1, 1A, 1B, and 1C. Figure 6 As shown, the endoscope 11 includes a scope 110 , a light source connector 111 , a mount adapter 112 , a relay lens 113 , a camera head 114 , and an operation switch 115 .

[0083] The mirror 110 is a thin and long light-guiding member that can guide light from the end to the front end, and is inserted into the body when used. The mirror 110 has an imaging window 110z at the front end, and an optical material such as optical glass or optical plastic is used in the imaging window 110z. The mirror 110 also has an optical fiber that guides the light introduced by the light source connector 111 to the front end and an optical fiber that transmits the optical image injected from the imaging window 110z.

[0084] The mount adapter 112 is a member for mounting the mirror 110 on the camera 114. Various mirrors 110 are detachably mounted on the mount adapter 112.

[0085] The light source connector 111 is used to guide the illumination light from the light emitting device to the affected part in the body. In this embodiment, the illumination light includes visible light and near infrared light. The light introduced into the light source connector 111 is guided to the front end of the mirror 110 via the optical fiber and is guided to the affected part in the body through the imaging window 110z. Figure 6 As shown, a transmission cable 111z for guiding illumination light from the light emitting device to the mirror 110 is connected to the light source connector 111. The transmission cable 111z may also include an optical fiber.

[0086] The relay lens 113 focuses the optical image transmitted through the mirror 110 on the imaging surface of the image sensor. In addition, the relay lens 113 can move the lens according to the operation amount of the operation switch 115 to adjust the focus and magnification.

[0087] The camera head 114 has a dichroic prism inside. The dichroic prism decomposes the light focused by the relay lens 113 into R light (red light), G light (green light), and B light (blue light). In addition, the dichroic prism can further decompose IR light (near infrared light). Thus, the endoscope 11 that can identify the lesion part by using the fluorescence imaging method using near infrared light is obtained.

[0088] Furthermore, the camera head 114 has an image sensor as a detector inside. The image sensor converts the optical image formed on each imaging surface into an electrical signal. The image sensor is not particularly limited, and at least one of CCD (Charge Coupled Device) and CMOS (Complementary Metal Oxide Semiconductor) can be used. The image sensor is, for example, a dedicated sensor that receives light of B component (blue component), R component (red component) and G component (green component), respectively. In addition, the camera head 114 may further have a dedicated sensor that receives IR component (near infrared light component). Thus, the endoscope 11 that can identify a specific lesion site by using a fluorescence imaging method using near infrared light is obtained.

[0089] The camera head 114 may have a color filter inside to replace the dichroic prism. A color filter is provided on the imaging surface of the image sensor. For example, three color filters are provided, and the three color filters receive the light focused by the relay lens 113 and selectively transmit R light (red light), G light (green light), and B light (blue light). In addition, by further providing a color filter that selectively transmits IR light (near infrared light), the endoscope 11 that can identify a lesion using a fluorescence imaging method using near infrared light is obtained.

[0090] In the case of using a fluorescence imaging method using near-infrared light, the color filter that selectively transmits IR light preferably has a blocking film that cuts off the reflected component of near-infrared light (IR light) contained in the illumination light. As a result, only the fluorescence formed by IR light emitted by the fluorescent agent used in the fluorescence imaging method is imaged on the imaging surface of the image sensor for IR light. Therefore, it is easy to clearly observe the affected part that is illuminated by the fluorescent agent.

[0091] In addition, if Figure 6 As shown, the camera 114 is connected to a signal cable 114 z for transmitting an electrical signal from the image sensor to the CCU 12 described later.

[0092] In the endoscope 11 having such a configuration, light from the subject passes through the mirror 110 and is guided to the relay lens 113 , and then passes through the dichroic prism in the camera 114 to form an image on the image sensor.

[0093] like Figure 7 As shown, an endoscope system 100 of the present embodiment includes an endoscope 11 for forming an image inside a subject, a CCU (Camera Control Unit) 12, light emitting devices 1, 1A, 1B, 1C, and a display device 13 such as a monitor.

[0094] The CCU 12 includes at least an RGB signal processing unit, an IR signal processing unit, and an output unit. The CCU 12 implements the functions of the RGB signal processing unit, the IR signal processing unit, and the output unit by executing a program stored in a memory inside or outside the CCU 12 .

[0095] The RGB signal processing unit converts the electrical signals of the B, R, and G components from the image sensor into image signals that can be displayed on the display device 13 and outputs them to the output unit. In addition, the IR signal processing unit converts the electrical signals of the IR components from the image sensor into image signals and outputs them to the output unit.

[0096] The output unit outputs at least one of the image signals of the RGB color components and the image signal of the IR component to the display device 13. For example, the output unit outputs the image signal based on any one of the synchronous output mode and the superimposed output mode.

[0097] In the synchronous output mode, the output unit synchronously outputs the RGB image and the IR image through different screens. In the synchronous output mode, the RGB image and the IR image can be compared on different screens to observe the affected part. In the overlap output mode, the output unit outputs a composite image formed by overlapping the RGB image and the IR image. In the overlap output mode, for example, the affected part luminesced by the fluorescent agent used in the fluorescence imaging method can be clearly observed in the RGB image.

[0098] The display device 13 displays an image of an object such as an affected part on a screen based on an image signal from the CCU 12. In the case of the synchronous output mode, the display device 13 divides the screen into a plurality of screens and displays the RGB image and the IR image in parallel on each screen. In the case of the overlapped output mode, the display device 13 displays a composite image formed by overlapping the RGB image and the IR image on one screen.

[0099] As described above, the endoscope 11 of this embodiment includes the light emitting devices 1, 1A, 1B, 1C, and radiates the first wavelength converted light 7 from the imaging window 110z of the endoscope 110. Therefore, the endoscope 11 can be used to efficiently excite the photosensitizing substance collected in the affected part of the body and make the photosensitizing substance fully function.

[0100] In addition, when the endoscope 11 includes the light emitting device 1A or 1C including the second phosphor 8, the endoscope 11 radiates the second wavelength converted light 9 as visible light in addition to the first wavelength converted light 7. Therefore, by using the endoscope system 100, the position of the affected part can be identified and the first wavelength converted light 7 can be irradiated to the affected part.

[0101] Thus, the medical device of this embodiment includes the light emitting devices 1, 1A, 1B, and 1C. However, the medical device is not limited to an endoscope or an endoscope system, and the light emitting devices 1, 1A, 1B, and 1C can be applied to any medical device used in photodynamic therapy. For example, the light emitting devices 1, 1A, 1B, and 1C can also be used as a light source device for irradiating near-infrared light from the outside of a subject used in photodynamic therapy.

[0102] [Photodynamic therapy]

[0103] Next, the photodynamic therapy of this embodiment is described. The photodynamic therapy of this embodiment is a method using the above-mentioned light emitting device 1, 1A, 1B, 1C or medical device. Specifically, the photodynamic therapy of this embodiment includes the following steps: identifying the position of the lesion; applying a photosensitive substance to the subject; and irradiating the lesion that has come into contact with the photosensitive substance with the first wavelength converted light 7.

[0104] The photodynamic therapy of this embodiment first identifies the location of the lesion of the patient as the subject. The location of the lesion can be identified, for example, using fluorescence imaging. Fluorescence imaging is a method as follows: a fluorescent agent is applied to the subject to specifically gather at a tumor in the subject, and then the fluorescent agent is excited by light of a specific wavelength to image the fluorescence emitted by the fluorescent agent, thereby understanding the presence and location of the tumor.

[0105] Next, a photosensitive substance is applied to the subject so that the photosensitive substance is specifically gathered at the affected part. As described above, as the photosensitive substance applied to the subject, a substance that absorbs light in the near-infrared region and generates heat and active oxygen species can be used. In addition, the timing of applying the photosensitive substance to the subject may be before the location of the lesion is identified.

[0106] Then, the first wavelength converted light 7 is irradiated to the lesion after contact with the photosensitive substance. As described above, the first wavelength converted light 7 has a light component in the wavelength range of at least 700nm to 800nm, and its energy is 100mW or more. In addition, the light in the near-infrared region is not easily scattered by hemoglobin and water in the body and is easily transmitted through the body, so the first wavelength converted light 7 is transmitted through the body and strongly excites the photosensitive substance. The excited photosensitive substance generates heat and active oxygen species to destroy the tumor in contact.

[0107] As described above, the first wavelength converted light 7 has light components in the entire wavelength range of at least 700 nm to 800 nm, so even when the photosensitive substance undergoes a characteristic change, it can be efficiently excited. In addition, the first wavelength converted light 7 has a high energy of 100 mW or more, so it can excite the photosensitive substance located deep in the biological body and make the photosensitive substance fully function.

[0108] The method for specifying the position of the lesion is not limited to the fluorescence imaging method. For example, the position of the lesion can be specified by narrow-band imaging and image analysis. In addition, the position of the lesion can be grasped by visual observation during surgery. In this case, the light emitted by the light-emitting device can be directly irradiated to the lesion without being separated by an optical fiber or the like. In addition, the light emitted by the light-emitting device can be irradiated to the lesion using a fiber-type device such as an optical fiber. In addition, even in the case of surgery, when the position of the lesion is specified, fluorescence imaging, narrow-band imaging, and image analysis can be used.

[0109] Here, the patient's lesion includes not only the tumor but also new blood vessels. New blood vessels refer to blood vessels that are specifically formed around the tumor and have the function of promoting tumor proliferation and metastasis. The photodynamic therapy of this embodiment can make the photosensitive substance specifically gather in the new blood vessels and destroy them.

[0110] The photodynamic therapy of this embodiment can destroy regulatory T cells. Regulatory T cells refer to cells that control immune tolerance. In the surrounding environment of the tumor, regulatory T cells are activated, hindering the immune system's effect on the tumor. Therefore, through photodynamic therapy, photosensitive substances are specifically aggregated in regulatory T cells and destroyed, activating the immune system's effect, thereby treating tumors. Such a treatment method is sometimes also called photoimmunotherapy.

[0111] Example

[0112] Hereinafter, the light emitting device of this embodiment will be described in more detail with reference to examples, but this embodiment is not limited to these examples.

[0113] [Preparation of phosphor]

[0114] (Example 1)

[0115] The oxide phosphor used in Example 1 was synthesized using a preparation method utilizing a solid phase reaction. The phosphor of Example 1 is composed of (Y 0.98 Ce 0.02 )3Mg2(AlO4)(SiO4)2. When synthesizing the oxide phosphor, the following compound powder was used as a main raw material.

[0116] Yttrium oxide (Y2O3): purity 3N, Shin-Etsu Chemical Co., Ltd.

[0117] Cerium oxide (CeO2): Purity 4N, Shin-Etsu Chemical Co., Ltd.

[0118] Alumina (θ-Al2O3): Purity>4N5, Sumitomo Chemical Co., Ltd.

[0119] Magnesium oxide (MgO): Purity 4N, Kojundo Chemical Research Institute Co., Ltd.

[0120] Silicon dioxide (SiO2): Purity> 3N, Japan Aerosil Co., Ltd.

[0121] In order to improve the reactivity between the raw materials, alumina used was AKP-G008 manufactured by Sumitomo Chemical Co., Ltd. In addition, the following compound powders were used as reaction accelerators in the Examples.

[0122] Aluminum fluoride (AlF3): Purity 3N, Kojundo Chemical Research Institute Co., Ltd.

[0123] Potassium carbonate (K2CO3): purity 2N5, Kanto Chemical Co., Ltd.

[0124] First, a compound (Y 0.98 Ce 0.02 )3Mg2(AlO4)(SiO4)2. Next, the weighed raw materials and a trace amount of reaction accelerator were fully wet mixed with an appropriate amount of water (pure water) using a ball mill. The obtained mixed raw material was transferred to a container and dried overnight at 120°C using a dryer. Then, the dried mixed raw material was crushed using a mortar and pestle to prepare a calcined raw material.

[0125] The above-mentioned sintered raw materials were transferred to a small alumina crucible with a lid, and sintered in an atmosphere at 1600°C for 4 hours using a box-type electric furnace, and then the sintered material was gently crushed. The crushed sintered material was transferred to a small alumina crucible again. Next, the small alumina crucible containing the sintered material was placed inside a larger alumina crucible with carbon added, and the crucible lid was covered. Then, the alumina crucible was sintered at 1400°C for 2 hours using a box-type electric furnace. In this way, the sintered material was subjected to a reduction treatment by the CO gas generated by the sintering at 1400°C, thereby obtaining the phosphor of this example. The body color of the obtained phosphor is dark orange. In addition, for the convenience of the experiment, post-treatment was omitted.

[0126] (Example 2, Example 3)

[0127] The nitride phosphors used in Examples 2 and 3 were synthesized using a solid phase reaction preparation method. The phosphor in Example 2 is La 2.991 Ce 0.009 (Si,Al)6(N,O) 11-x The phosphor of Example 3 is a nitride phosphor represented by the composition formula of 2.982 Ce 0.012 (Si,Al)6(N,O) 11-x A nitride phosphor represented by the composition formula.

[0128] When synthesizing a nitride phosphor, lanthanum (III) nitride (LaN), silicon nitride powder (Si3N4), aluminum nitride powder (AlN), and cerium fluoride powder (CeF3) are used as main raw materials.

[0129] First, a compound La having a stoichiometric composition is prepared. 2.991 Ce 0.009 (Si,Al)6(N,O) 11-x ,La 2.982 Ce 0.012 (Si, Al)6(N, O) 11-x The above raw materials were weighed in the same manner as described above. However, LaN powder was weighed in an excess of 24% over the stoichiometric value.

[0130] Next, the weighed raw materials were dry mixed in a glove box in a nitrogen atmosphere using a mortar. The obtained mixed raw materials were added to a boron nitride crucible and fired at 1900°C for 2 hours in a nitrogen atmosphere of 0.5 MPa. Then, the fired product was cleaned for 1 hour with a 10% nitric acid solution. Thus, the phosphors of Examples 2 and 3 were obtained.

[0131] (Example 4)

[0132] The oxide phosphor used in Example 4 was synthesized by a preparation method using a solid phase reaction. The phosphor in Example 4 is composed of (Ca 0.1 Sr 0.897 Eu 0.003 ) The oxide phosphor represented by the composition formula of Sc2O4. In addition, when synthesizing the oxide phosphor, the following compound powder was used as the main raw material.

[0133] Calcium carbonate (CaCO3): Purity 3N, Wako Pure Chemical Industries, Ltd.

[0134] Strontium carbonate (SrCO3): Purity 3N, Wako Pure Chemical Industries, Ltd.

[0135] Scandium oxide (Sc2O3): purity 3N, Shin-Etsu Chemical Co., Ltd.

[0136] Europium oxide (Eu2O3): purity 3N, Shin-Etsu Chemical Co., Ltd.

[0137] First, a compound (Ca 0.1 Sr 0.897 Eu 0.003 )Sc2O4. Next, the weighed raw materials were put into a beaker with pure water and stirred for 1 hour using a magnetic stirrer. Thus, a slurry-like mixed raw material formed by pure water and the raw materials was obtained. Then, a dryer was used to dry the total amount of the slurry-like mixed raw material. Then, a mortar and pestle were used to crush the dried mixed raw material to prepare a calcined raw material.

[0138] The sintered raw material was transferred to a small alumina crucible and subjected to reduction treatment for 1 hour in a reducing gas (96 volume % N2 + 4 volume % H2) atmosphere at 1500°C using a tubular atmosphere furnace, thereby obtaining the phosphor of this example. In addition, the flow rate of the reducing gas was set to 1 L / min, and the heating and cooling rate was set to 300°C / hour.

[0139] The body color of the obtained phosphor was light purple, which means that the phosphor of Example 4 absorbs visible light (such as blue light, green light, yellow light, and red light) other than purple light relatively strongly.

[0140] (Example 5)

[0141] The nitride phosphor used in Example 5 was synthesized using a preparation method utilizing a solid phase reaction. The phosphor in Example 5 is composed of (La 0.896 G 0.1 Ce 0.004 )3(Si,Al)6(N,O) 11-x A nitride phosphor represented by the composition formula.

[0142] When synthesizing the nitride phosphor, lanthanum (III) nitride (LaN), gadolinium (III) nitride (GdN), silicon nitride powder (Si3N4), aluminum nitride powder (AlN), and cerium nitride powder (CeN) are used as main raw materials.

[0143] First, a compound (La 0.896 G 0.1 Ce 0.004 )3(Si,Al)6(N,O) 11-xThe above raw materials were weighed in a manner. Next, the weighed raw materials were dry mixed in a glove box in a nitrogen atmosphere using a mortar. The obtained mixed raw materials were added to a crucible made of boron nitride and sintered at 1900°C for 2 hours in a nitrogen atmosphere of 0.5 MPa. Then, the sintered product was cleaned in a 10% nitric acid solution for 1 hour. Thus, the phosphor of Example 5 was obtained. The body color of the obtained phosphor was light red.

[0144] (Example 6)

[0145] The oxide phosphor used in Example 6 was synthesized by a solid phase reaction method. The phosphor in Example 6 is composed of Gd3(Ga 0.97 Cr 0.03 )2Ga3O 12 The phosphor of Example 6 is Cr 3+ Activating the phosphor. When synthesizing the oxide phosphor of Example 6, the following compound powder was used as a main raw material.

[0146] Gadolinium oxide (Gd2O3): Purity 3N, Wako Pure Chemical Industries, Ltd.

[0147] Gallium oxide (Ga2O3): Purity 4N, Wako Pure Chemical Industries, Ltd.

[0148] Chromium oxide (Cr2O3): Purity 3N, Kojundo Chemical Research Institute Co., Ltd.

[0149] First, a compound Gd3(Ga 0.97 Cr 0.03 )2Ga3O 12 The raw materials were weighed in a manner. Next, the weighed raw materials were put into a beaker with pure water and stirred for 1 hour using a magnetic stirrer. Thus, a slurry-like mixed raw material formed by pure water and the raw materials was obtained. Then, a dryer was used to dry the total amount of the slurry-like mixed raw material. Then, the dried mixed raw material was crushed using a mortar and pestle to prepare a calcined raw material.

[0150] The calcined raw material was transferred to a small alumina crucible and calcined in a box-type electric furnace at 1500°C for 1 hour in the atmosphere to obtain the phosphor of this example. The temperature rise and fall rate was set to 400°C / hour. The body color of the obtained phosphor was dark green.

[0151] (Example 7)

[0152] The oxide phosphor used in Example 7 was synthesized by a preparation method using a solid phase reaction. The phosphor in Example 7 is composed of (Gd 0.75La 0.25 )3(Ga 0.97 Cr 0.03 )2Ga3O 12 The phosphor of Example 7 is Cr 3+ Activating the phosphor. Next, when synthesizing the oxide phosphor of Example 7, the following compound powder was used as a main raw material.

[0153] Gadolinium oxide (Gd2O3): Purity 3N, Wako Pure Chemical Industries, Ltd.

[0154] Lanthanum oxide (La2O3): Purity 3N, Wako Pure Chemical Industries, Ltd.

[0155] Gallium oxide (Ga2O3): Purity 4N, Wako Pure Chemical Industries, Ltd.

[0156] Chromium oxide (Cr2O3): Purity 3N, Kojundo Chemical Research Institute Co., Ltd.

[0157] First, a compound (Gd 0.75 La 0.25 )3(Ga 0.97 Cr 0.03 )2Ga3O 12 The raw materials were weighed in a manner. Next, the weighed raw materials were put into a beaker with pure water and stirred for 1 hour using a magnetic stirrer. Thus, a slurry-like mixed raw material formed by pure water and the raw materials was obtained. Then, a dryer was used to dry the total amount of the slurry-like mixed raw material. Then, the dried mixed raw material was crushed using a mortar and pestle to prepare a calcined raw material.

[0158] The calcined raw material was transferred to a small alumina crucible and calcined in an atmosphere at 1450°C for 1 hour using a box-type electric furnace to obtain the phosphor of this example. The temperature rise and fall rate was set to 400°C / hour. The body color of the obtained phosphor was dark green.

[0159] [evaluate]

[0160] (Crystal Structure Analysis)

[0161] The crystal structure of the phosphor of Example 1 was evaluated using an X-ray diffraction apparatus (X'Pert PRO; manufactured by Spectris Corporation and PANalytical).

[0162] Although the details are omitted, it can be seen from the evaluation results that the phosphor of Example 1 is mainly composed of a compound having a garnet crystal structure. In other words, it can be seen that the phosphor of Example 1 is a garnet phosphor. In this way, it is confirmed that the phosphor of Example 1 is a compound (Y 0.98 Ce 0.02 )3Mg2(AlO4)(SiO4)2.

[0163] Next, the crystal structures of the phosphors of Examples 2 and 3 were evaluated using an X-ray diffraction apparatus (RINT2100; manufactured by Rigaku Corporation).

[0164] The details are omitted, but the evaluation results show that the phosphors of Examples 2 and 3 are mainly composed of a tetragonal crystal compound. 11 The crystal structure of the nitride crystals shown is almost the same. That is, it can be seen that the phosphors of Example 2 and Example 3 are nitride phosphors. In this way, it is confirmed that the phosphors of Example 2 and Example 3 are each La as a compound. 2.991 Ce 0.009 (Si,Al)6(N,O) 11-x and La 2.982 Ce 0.012 (Si,Al)6(N,O) 11-x .

[0165] Next, the crystal structure of the phosphor of Example 4 was evaluated using an X-ray diffraction apparatus (MiniFlex; manufactured by Rigaku Corporation).

[0166] Figure 8 The X-ray diffraction (XRD) pattern of the phosphor of Example 4 is shown ((1) in the figure). For reference, Figure 8 The pattern of CaSc2O4 registered in ICSD (Inorganic Crystal Structure Database) is shown ((2) in the figure). Figure 8 It can be determined that the XRD pattern of the phosphor of Example 4 is consistent with the pattern of CaSc2O4 registered in ICSD. This indicates that the phosphor of Example 4 is a compound having the same calcium ferrite type crystal structure as CaSc2O4.

[0167] In addition, the diffraction peak of the phosphor of Example 4 is located at a lower angle than the diffraction peak of CaSc2O4 registered in ICSD. The low-angle shift of the diffraction peak shows an increase in the interplanar spacing value (d value) of the crystal. Therefore, this result indicates that Sr, which has a relatively large ionic radius, is more likely to be used as a phosphor. 2+ (The ionic radius is 8 coordination) is formed into CaSc2O4:Eu 2+ The Ca of phosphor crystals 2+ (The ionic radius is 8 coordination) partly replaced, the lattice spacing of the crystal became larger. Based on the above results, Example 4 is considered to be composed of (Ca 0.1 Sr 0.897 Eu 0.003 )Oxide phosphor represented by the composition formula of Sc2O4.

[0168] Next, the crystal structure of the phosphor of Example 5 was evaluated using an X-ray diffraction apparatus (MiniFlex; manufactured by Rigaku Corporation).

[0169] The details are omitted, but the evaluation results show that the phosphor of Example 5 is mainly composed of a crystalline compound having tetragonal crystals. Furthermore, it is known that the phosphor of Example 5 has a structure similar to that of the general formula La3Si6N 11 The crystal structure of the nitride crystal represented by is almost the same. That is, it can be seen that the phosphor of Example 5 is a nitride phosphor. In this way, it is confirmed that the phosphor of Example 5 is a compound (La 0.896 G 0.1 Ce 0.004 )3(Si,Al)6(N,O) 11-x .

[0170] Next, the crystal structure of the phosphor of Example 6 was evaluated using an X-ray diffraction apparatus (MiniFlex; manufactured by Rigaku Corporation).

[0171] Although the details are omitted, it can be seen from the evaluation results that the phosphor of Example 6 is mainly composed of a compound having a garnet crystal structure. In other words, it can be seen that the phosphor of Example 6 is a garnet phosphor. In this way, it is confirmed that the phosphor of Example 6 is a compound of Gd3 (Ga 0.97 Cr 0.03 )2Ga3O 12 .

[0172] Next, the crystal structure of the phosphor of Example 7 was evaluated using an X-ray diffraction apparatus (MiniFlex; manufactured by Rigaku Corporation).

[0173] Although the details are omitted, it can be seen from the evaluation results that the phosphor of Example 7 is mainly composed of a compound having a garnet crystal structure. In other words, it can be seen that the phosphor of Example 7 is a garnet phosphor. In this way, it is confirmed that the phosphor of Example 7 is a compound (Gd 0.75 La 0.25 )3(Ga 0.97 Cr0.03 )2Ga3O 12 .

[0174] (Spectral characteristics)

[0175] Next, the excitation characteristics and fluorescence characteristics of the phosphor of Example 1 were evaluated using a spectrofluorophotometer (FP-6500; manufactured by JASCO Corporation). Fig. 9 The excitation spectrum and fluorescence spectrum of the phosphor of Example 1 are shown. In addition, the excitation wavelength during the fluorescence spectrum measurement is set to 450nm, and the monitoring wavelength during the excitation spectrum measurement is set to the fluorescence peak wavelength. Fig. 9 For example, both the fluorescence spectrum and the excitation spectrum are normalized with the peak as 1.

[0176] The fluorescence spectrum of the phosphor of Example 1 is considered to be caused by Ce 3+ 5D 1 →4f 1 The fluorescence spectrum of the phosphor of Example 1 forms a band spectrum in the entire wavelength range of 600 nm to 800 nm.

[0177] In addition, the peak wavelengths of the fluorescence spectrum and excitation spectrum of the phosphor of Example 1 are 625 nm and 473 nm, respectively. This means that the phosphor of Example 1 can efficiently absorb blue light with a wavelength of about 430 to 480 nm and convert it into fluorescence with a band spectrum in the wavelength range of 600 to 800 nm.

[0178] Next, the excitation characteristics and fluorescence characteristics of the phosphor of Example 2 were evaluated in the same manner as in Example 1 using a spectrofluorophotometer. Fig.10 The excitation spectrum and fluorescence spectrum of the phosphor of Example 2 are shown. In addition, the excitation wavelength during the fluorescence spectrum measurement is set to 540 nm, and the monitoring wavelength during the excitation spectrum measurement is set to the fluorescence peak wavelength. Fig.10 For example, both the fluorescence spectrum and the excitation spectrum are normalized with the peak as 1.

[0179] The fluorescence spectrum of the phosphor in Example 2 is considered to be caused by Ce 3+ 5D 1 →4f 1 Moreover, the fluorescence spectrum of the phosphor of Example 2 forms a band spectrum in the entire wavelength range of 600nm to 800nm.

[0180] In addition, the peak wavelengths of the fluorescence spectrum and excitation spectrum of the phosphor of Example 2 are 630 nm and 531 nm, respectively. This means that the phosphor of Example 2 can efficiently absorb green to yellow light with a wavelength of 510 nm to 560 nm and convert it into fluorescence with a spectrum in the wavelength range of 600 nm to 800 nm.

[0181] Next, the fluorescence characteristics of the phosphor of Example 3 were evaluated in the same manner as in Example 1 using a spectrofluorophotometer. Fig.11 The fluorescence spectrum of the phosphor of Example 3 is shown. In addition, the excitation wavelength during the fluorescence spectrum measurement is set to 540 nm. Fig.11 For example, the fluorescence spectra are normalized with the peak as 1. Fig.11 For the sharp spectrum near 540nm in the image, the monochromatic light used as excitation light is the light component reflected by the fluorescent body.

[0182] The fluorescence spectrum of the phosphor in Example 3 is considered to be caused by Ce 3+ 5D 1 →4f 1 The fluorescence spectrum of the phosphor of Example 3 forms a band spectrum in the wavelength range of 600nm to 800nm. In addition, the peak wavelength in the fluorescence spectrum of the phosphor of Example 3 is 634nm.

[0183] The above content indicates that the phosphor of Example 3 can absorb light of a single wavelength near 540 nm and convert the wavelength into fluorescence with a spectrum in the wavelength range of 600 nm to 800 nm.

[0184] Next, the fluorescence characteristics of the phosphor of Example 4 were evaluated using a spectrofluorophotometer. Fig.12 The fluorescence spectrum of the phosphor of Example 4 is shown. In addition, the excitation wavelength in the fluorescence spectrum measurement was set to 460 nm.

[0185] The fluorescence spectrum of the phosphor of Example 4 is considered to be caused by Eu 2+ 4f 6 5d 1 →4f 7 Moreover, the fluorescence spectrum of the phosphor of Example 4 is considered to form a band spectrum as a whole in the wavelength range of 700nm to 800nm. In addition, those skilled in the art can clearly understand that the long-wavelength component in the fluorescence spectrum of the phosphor of Example 4 contains a little noise, but has a light component as a whole in the wavelength range of 700nm to 800nm.

[0186] The above indicates that the phosphor of Example 4 can absorb blue light with a wavelength of about 460 nm and convert the wavelength into fluorescence with a band spectrum in the wavelength range of 700 nm to 800 nm. In addition, the half-peak width in the fluorescence spectrum of the phosphor of Example 4 is about 100 nm.

[0187] Next, the fluorescence characteristics of the phosphor of Example 5 were evaluated using a spectrofluorophotometer. Fig.13 The fluorescence spectrum of the phosphor of Example 5 is shown. In addition, the excitation wavelength during the fluorescence spectrum measurement is set to 540 nm. Fig.13 For the sharp spectrum near 540nm in the image, the monochromatic light used as excitation light is the light component reflected by the fluorescent body.

[0188] The fluorescence spectrum of the phosphor of Example 5 is considered to be caused by Ce 3+ 5D 1 →4f 1 Moreover, the fluorescence spectrum of the phosphor of Example 5 is considered to be a spectrum that forms a band spectrum as a whole in the wavelength range of at least 700nm to 800nm. In addition, the fluorescence spectrum of the phosphor of Example 5 is also considered to be a spectrum that forms a band spectrum as a whole in the wavelength range of 600nm to 800nm.

[0189] The above content indicates that the phosphor of Example 5 can absorb green light with a wavelength of about 540nm, and convert the wavelength into fluorescence with a wavelength range of 700nm to 800nm. In addition, the above content indicates that the phosphor of Example 5 absorbs green light with a wavelength of about 540nm, and converts the wavelength into fluorescence with a wavelength range of 600nm to 800nm. In addition, the half-peak width in the fluorescence spectrum of the phosphor of Example 5 is about 160nm.

[0190] Next, the excitation characteristics and fluorescence characteristics of the phosphor of Example 6 were evaluated using a spectrofluorophotometer. Fig.14 The excitation spectrum and fluorescence spectrum of the phosphor of Example 6 are shown. In addition, the excitation wavelength during the fluorescence spectrum measurement is set to 450nm, and the monitoring wavelength during the excitation spectrum measurement is set to the fluorescence peak wavelength. Fig.14 The emission intensities are normalized and shown so that the emission intensities of the fluorescence spectrum and the excitation spectrum are the same.

[0191] The fluorescence spectrum of the phosphor of Example 6 is considered to be caused by Cr 3+ The fluorescence spectrum of the phosphor of Example 6 is a spectrum that is considered to form a band spectrum in the wavelength range of 700nm to 800nm. In addition, the peak wavelength of the fluorescence spectrum in the phosphor of Example 6 is 735nm.

[0192] In addition, by Fig.14 It can be determined that the phosphor of Example 6 has strong excitation bands in the wavelength region of 400nm to 500nm and the wavelength region of 580nm to 680nm. In other words, the phosphor of Example 6 is a phosphor that strongly absorbs purple to blue-green light and orange to deep red light and emits fluorescence.

[0193] The above content indicates that the phosphor of Example 6 is excited by a solid light emitting element that emits at least one light selected from purple, blue, cyan, orange, red and deep red. Moreover, it indicates that the phosphor of Example 6 can convert the wavelength of the excitation light into fluorescence that forms a band spectrum as a whole in the wavelength range of 700nm to 800nm. In addition, the half-peak width in the fluorescence spectrum of the phosphor of Example 6 is about 100nm.

[0194] Next, a wavelength converter containing the phosphor of Example 7 was prepared, and the fluorescence characteristics were evaluated. Specifically, first, the phosphor of Example 7 was made into a granular form using a manual press, thereby preparing a wavelength converter. Next, the obtained wavelength converter was excited with a laser, and the energy of the fluorescence emitted by the wavelength converter at this time (the radiation beam of the fluorescence) was measured. At this time, the central wavelength of the laser was set to 445nm. In addition, the energy of the laser varied from 0.93W to 3.87W. A power meter was used in the evaluation of the energy of the laser. In addition, an integrating sphere was used to evaluate the energy of the fluorescence emitted by the wavelength converter.

[0195] Table 1

[0196] Laser energy (W) <![CDATA[Energy density of the laser (W / mm 2 )]]> Energy of wavelength converted light (mW) 0.93 0.73 199 1.67 1.31 346 2.4 1.89 484 3.14 2.46 610 3.87 3.04 700

[0197] The energy of the fluorescence emitted from the wavelength converter when the energy of the laser light was changed from 0.93 W to 3.87 W is shown in Table 1. For reference, the energy density of the laser light is also shown in Table 1.

[0198] As shown in Table 1, the wavelength converter emits light with an energy of 100 mW or more. Furthermore, when the energy of the laser is increased from 0.93 W to 3.87 W, the wavelength converter also emits high-energy light. That is, it is known that: 3+ The activated phosphor can maintain high luminous efficiency even in the region where the energy of the excitation light is high. This result is surprising because it is very different from the prior art common sense that a phosphor with short afterglow (less than 10 μs) must be used to suppress the saturation of the fluorescence output. In addition, considering that the phosphor generates heat and the temperature of the phosphor rises when the phosphor is excited by a high-energy laser, the phosphor of Example 7 can be said to be an excellent phosphor with less reduction in luminous efficiency due to temperature rise.

[0199] Fig.15 The fluorescence spectrum of the wavelength converter containing the phosphor of Example 7 is shown in FIG. 1 when the wavelength converter containing the phosphor of Example 7 is excited by a laser with an energy of 3.87 W. The fluorescence spectrum of the wavelength converter containing the phosphor of Example 7 is considered to be caused by Cr 3+ The fluorescence spectrum is a spectrum that is considered to form a band spectrum in the wavelength range of 700nm to 800nm. In addition, the peak wavelength of the fluorescence spectrum when the wavelength converter containing the phosphor of Example 7 is excited by a laser with an energy of 3.87W is 767nm. In addition, the half-peak width of the peak of the fluorescence spectrum is about 100nm.

[0200] As mentioned above, the contents of the present embodiment have been described with reference to the examples. However, it is obvious to those skilled in the art that the present embodiment is not limited to these described contents, and various modifications and improvements can be made.

[0201] The entire contents of Tokugan 2019-017797 (filing date: February 4, 2019) are incorporated herein by reference.

[0202] Industrial Applicability

[0203] According to the present application, a light-emitting device capable of radiating near-infrared light that efficiently excites a photosensitive substance and a medical device using the light-emitting device can be provided.

[0204] Explanation of symbols

[0205] 1, 1A, 1B, 1C Light-emitting device

[0206] 2 Solid-state light-emitting devices

[0207] 3. 3A wavelength converter

[0208] 4. First phosphor

[0209] 6 Primary Light

[0210] 7 First wavelength converted light

[0211] 8 Second phosphor

[0212] 9 Second wavelength converted light

Claims

1. A light emitting device for use in photodynamic therapy, It has a solid light emitting element and a wavelength converter. The energy density of the solid light emitting element is 0.5W / mm 2 Above the primary light, The wavelength converter includes a first phosphor that emits a first wavelength converted light. in, The solid-state light-emitting element comprises a plurality of elements of the same type, The first wavelength converted light has a light component in the entire wavelength range of at least 700 nm and less than 800 nm. The fluorescence peak of the first wavelength converted light is within the wavelength range of 700nm to 1000nm, The energy of the fluorescence emitted by the wavelength converter is 100 mW or more.

2. The light emitting device according to claim 1, wherein: The first wavelength converted light has a light component entirely within a wavelength range of 600 nm to 800 nm.

3. The light emitting device according to claim 1 or 2, wherein: The wavelength converter further includes a second phosphor that absorbs the primary light emitted by the solid-state light emitting element and emits second wavelength converted light as visible light.

4. The light emitting device according to claim 3, wherein: The first phosphor emits the first wavelength converted light by absorbing at least one of the primary light and the second wavelength converted light.

5. The light emitting device according to claim 1 or 2, wherein: The first phosphor includes Eu 2+ Activate phosphor and Ce 3+ At least one of the phosphors is activated.

6. The light emitting device according to claim 1 or 2, wherein: The first phosphor includes Cr 3+ Activate the phosphor.

7. The light emitting device according to claim 3, wherein: The peak wavelength of the fluorescence emitted by the second phosphor is within the wavelength range of 500nm to 700nm. The solid-state light emitting element includes a blue laser element as an excitation source.

8. The light emitting device according to claim 1 or 2, wherein: The solid-state light emitting element radiates the primary light having an intensity maximum within a wavelength range of 430 nm to 480 nm, 500 nm to 560 nm, or 600 nm to 700 nm. 9 . A medical device comprising the light emitting device according to claim 1 .

Citation Information

Patent Citations

  • beam-emitting optoelectronic element

    JP2018518046A

  • Game machine

    JP2019017797A

  • Fiber light source, endoscope, and endoscope system

    CN107851950A

  • Light source apparatus and light-emitting apparatus

    CN108966666A

  • Endoscope light emitting device, endoscope using same, and fluorescence imaging method

    CN111885953A